# Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents

> **NCT01252862** · PHASE4 · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 40 (estimated)

## Conditions studied

- Subjects With Primary Open-angle Glaucoma (POAG)

## Interventions

- **DEVICE:** iStent

## Key facts

- **NCT ID:** NCT01252862
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2016-07
- **Final completion:** 2016-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01252862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01252862, "Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01252862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*